Synpromics Ltd, the leader in gene control, today announces a new research partnership with Solid Biosciences, LLC.
New data from the SGT-001 preclinical program was published today in Molecular Therapy – Methods and Clinical Development.
We are getting ready to initiate a clinical study for our gene transfer candidate, SGT-001, later this year.
Solid Biosciences is pleased to announce additional research grant from our Australia-based partner Save Our Sons and an initial research grant from Ireland-based Join Our Boys.
Solid Biosciences to Initiate Clinical Program for Gene Therapy Candidate in Coming Months
Please subscribe to receive our latest news